Therapeutic options in the treatment of psoriasis and atopic dermatitis
- 1 July 2005
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 53 (1), S3-S16
- https://doi.org/10.1016/j.jaad.2005.04.026
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 2004
- Safety of large area application of a novel vitamin D analogue (Tisocalcitate ointment) in patients with chronic plaque type psoriasisJournal of the American Academy of Dermatology, 2004
- Safety of large area application of a novel vitamin D analogue (Tisocalcitate ointment) in healthy volunteersJournal of the American Academy of Dermatology, 2004
- Oral tazarotene and difficult-to-treat psoriatic lesionsJournal of the American Academy of Dermatology, 2004
- Safety of oral tazarotene in moderate to severe plaque psoriasisJournal of the American Academy of Dermatology, 2004
- Quality of life effect of oral tazarotene in patients with moderate to severe psoriasis as measured by the 12-item psoriasis quality of life questionnaire (PQOL-12)Journal of the American Academy of Dermatology, 2004
- A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasisJournal of the American Academy of Dermatology, 2004
- Recombinant interferon gamma therapy for atopic dermatitisJournal of the American Academy of Dermatology, 1993
- Azathioprine in dermatologyJournal of the American Academy of Dermatology, 1991
- Incidence of skin cancers in patients with atopic dermatitis treated with coal tar: A 25-year follow-up studyJournal of the American Academy of Dermatology, 1980